Ventricular Arrhythmia With Cessation of Infliximab in a Patient With Ankylosing Spondylitis
Infliximab is an anti-tumor necrosis factor alpha agent, which is indicated for the treatment of resistant ankylosing spondylitis bostik roll-cote (AS).We presented a patient with AS who developed ventricular tachycardia after premature cessation of infliximab.Ventricular tachycardia did not recur after restarting of infliximab treatment.This case